Dec 15, 2022 / 05:00PM GMT
Allison Soss - KCSA Strategic Communications - SVP
Hello, and welcome to the KCSA Mental Health Virtual Investor Conference. My name is Allison Soss, and on behalf of KCSA Strategic Communications, as well as their co-host, the OTC Markets Group, we're very pleased you have joined us for our next live presentation from Filament Health.
(Operator Instructions) On a final note, all today's presentations will be recorded and available for 24/7 replay. At this point, I'm very pleased to welcome Ben Lightburn, CEO and Co-Founder of Filament Health Corp., which trades on the OTCQB Venture Market under this under the symbol FLHLF and on the NEO under the symbol FH. Welcome, Ben.
Ben Lightburn - Filament Health Corp. - CEO & Co-Founder
Thank you very much. Pleasure to be here. Filament Health is a naturally focused psychedelic drug development company. And we have a few highlights here for you as I can manipulate the thing.
We are the first and still only company to actually have naturally derived drug candidates in FDA approved clinical trial. We
Filament Health Corp at OTC Markets KCSA Mental Health Investor Conference Transcript
Dec 15, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers